Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling

1. Dave, B.
2. Granados-Principal, S.
3. Zhu, R.
4. Benz, S.
5. Rabizadeh, S.
6. Soon-Shiong, P.
7. Yu, K.-D.
8. Shao, Z.
9. Li, X.
10. Gilcrease, M.
11. Lai, Z.
12. Chen, Y.
13. Huang, T.H.-M.
14. Shen, H.
15. Liu, X.
16. Ferrari, M.
17. Zhan, M.
18. Wong, S.T.C.
19. Kumaraswami, M.
20. Mittal, V.
21. Chen, X.
22. Gross, S.S.
23. Chang, J.C.